Hypoglycemia: Differential Diagnosis

1. Confirming the Diagnosis: Whipple's Triad

Before launching into a complex workup, the first step is to confirm that a true hypoglycemic disorder exists. The clinical standard for this is Whipple's Triad.

For a concise introduction to this essential concept and the typical symptoms of hypoglycemia, let's watch a short video.

To summarize, Whipple's Triad consists of:

1. Symptoms consistent with hypoglycemia (e.g., sweating, tremor, confusion, seizure).
2. A documented low plasma glucose level at the time of symptoms (typically < 55 mg/dL or 3.0 mmol/L).
3. Resolution of symptoms after glucose is administered.

It's critical to note that capillary blood glucose from a fingerstick is useful for screening but should be confirmed with a plasma glucose level drawn from a vein, as fingerstick meters can be inaccurate at low ranges.

2. Building the Differential Diagnosis: A Framework

Once you've confirmed true hypoglycemia, the next step is to figure out why it's happening. A helpful initial framework is to categorize patients as either critically ill or seemingly well.

• In the critically ill patient: Hypoglycemia is often a complication of their underlying condition. Common causes include sepsis, liver failure, renal failure, malnutrition, and adrenal insufficiency (due to the stress of illness).
• In the seemingly well patient: The differential is different and requires a more detailed investigation into endocrine causes, medications, and factitious disorders.

The following chart provides an excellent visual overview of the broad categories of causes.

As you can see, the list of potential causes is long. However, a few key laboratory tests, drawn during a hypoglycemic episode, can rapidly narrow the possibilities.

3. The Essential Laboratory Workup

When a patient presents with unexplained hypoglycemia that meets Whipple's triad, your most important action is to "seize the moment" and draw blood for a specific set of tests before you give them glucose (if clinically safe to do so).

The key initial tests are:

1. Plasma Glucose: To confirm the hypoglycemia.
2. Serum Insulin: To see if the body is producing insulin appropriately.
3. Serum C-peptide: To determine if the insulin is from an internal (endogenous) or external (exogenous) source.
4. Serum Beta-hydroxybutyrate: A ketone body that helps differentiate insulin-mediated from non-insulin-mediated causes.
5. Screen for Oral Hypoglycemic Agents: To check for drugs like sulfonylureas.

The Crucial Role of Insulin and C-peptide

Understanding the relationship between insulin and C-peptide is the most important concept in this workup. When the pancreas releases insulin, it does so by cleaving a larger molecule called proinsulin into two pieces: active insulin and an inactive fragment called C-peptide. They are released in a 1:1 ratio.

• Endogenous Insulin (from the pancreas): Results in HIGH insulin and HIGH C-peptide.
• Exogenous Insulin (from an injection): Contains only insulin, no C-peptide. This results in HIGH insulin but LOW C-peptide.

This next video explains this critical distinction perfectly.

4. Interpreting Laboratory Patterns

Now, let's put this all together into a practical, pattern-based approach. The key is to interpret the insulin and C-peptide levels relative to the low glucose. Normally, when blood glucose is low, insulin secretion should be suppressed. If it's not, something is wrong.

To learn these patterns, please carefully study the following reference table from the comprehensive endocrinology textbook, Endotext.

Let's walk through the main patterns you derived from that table:

Pattern 1: Insulin-Mediated Hypoglycemia

(Labs show inappropriately high insulin for the level of glucose, and suppressed ketones)

• High Insulin, High C-peptide: This indicates endogenous hyperinsulinism. The body is making too much of its own insulin.

  • Differential:
    1. Insulinoma: A rare, insulin-secreting tumor of the pancreas.
    2. Sulfonylurea Use: These drugs stimulate the pancreas to release insulin.
  • Next Step: Check a screen for oral hypoglycemic agents. If positive, you've found the cause. If negative, the suspicion for insulinoma is very high.

• High Insulin, Low C-peptide: This pattern is pathognomonic for exogenous insulin administration (i.e., the patient injected insulin).

Pattern 2: Non-Insulin-Mediated Hypoglycemia

(Labs show appropriately suppressed insulin and C-peptide)

• Low Insulin, Low C-peptide: This tells you the problem is NOT excess insulin.
  • Differential:
    1. Critical Illness: Sepsis, organ failure (liver, kidney, heart).
    2. Hormone Deficiencies: Primarily adrenal insufficiency (lack of cortisol).
    3. Non-Islet Cell Tumors: Rare tumors that can secrete IGF-2, a hormone that acts like insulin.
    4. Alcohol/Starvation: Alcohol impairs gluconeogenesis, especially in a malnourished person.

5. Application through Clinical Cases

Let's see how these principles apply in real-world scenarios. The following article provides three excellent case studies that highlight different causes of hypoglycemia.

• Case 1 & 3 (Adrenal Insufficiency): These patients would have Low Insulin and Low C-peptide. Without cortisol, the body cannot effectively maintain glucose levels, especially under stress. The hypoglycemia appropriately suppresses pancreatic insulin secretion.
• Case 2 (Glyburide Error): This patient had High Insulin and High C-peptide. The sulfonylurea drug forced his pancreas to secrete insulin, leading to the high levels of both molecules, which would have been confirmed by a positive sulfonylurea screen.

These cases underscore that while insulinoma is often what students think of first, hypoglycemia is more commonly related to medications, critical illness, or other endocrine disorders like adrenal insufficiency.

Conclusion

You are now equipped with a systematic framework to approach a patient with hypoglycemia. By confirming the diagnosis with Whipple's Triad and ordering the correct initial labs, you can efficiently narrow a broad differential diagnosis into a few likely possibilities.

Key Takeaways:

• Always confirm true hypoglycemia using Whipple's Triad (symptoms, low plasma glucose, resolution with treatment).
• When faced with unexplained hypoglycemia, the crucial labs to draw during the episode are plasma glucose, insulin, C-peptide, and beta-hydroxybutyrate.
• The relationship between insulin and C-peptide is key:
  • High Insulin + High C-peptide = Endogenous (Insulinoma or Sulfonylurea)
  • High Insulin + Low C-peptide = Exogenous (Insulin Injection)
  • Low Insulin + Low C-peptide = Not insulin-mediated (e.g., adrenal insufficiency, organ failure, alcohol)
• Remember to consider common causes like medications (especially sulfonylureas), critical illness, and alcohol before jumping to rare diagnoses like insulinoma.

Preview of the Next Lesson:
We will continue our exploration of key endocrine lab tests by moving to the thyroid. In the next lesson, you will learn to interpret TSH and free T4 patterns to diagnose primary hypothyroidism and hyperthyroidism, another fundamental skill in clinical medicine.